Restylane is the trade name for a range of injectable fillers with a specific formulation of hyaluronic acid (HA) of non-animal origin. In the United States, Restylane was the first hyaluronic acid filler approved by the U. S. Food and Drug Administration (FDA) for cosmetic injection into subdermal facial tissues.
This approval expands usage to include lip augmentation and wrinkle correction. Most dermal fillers have a temporary effect, because they contain materials that are absorbed by the body over time. The FDA has approved only one product made of a material that stays in the body and is not absorbed. Some dermal fillers also contain lidocaine, which aims to reduce pain or discomfort related to the injection. Availability of Restylane Contour Galderma will work closely with its aesthetic injector partners to introduce Restylane Contour to their respective practice centers across the country starting this summer.
Do not use if you have severe allergies with a history of severe reactions (anaphylaxis), are allergic to lidocaine or proteins from gram-positive bacteria used to produce hyaluronic acid, are prone to bleeding, or have a bleeding disorder. The safety of use during pregnancy or lactation has not been studied. Tell your doctor if you have a history of scarring or pigmentation disorders, as these side effects can occur with hyaluronic acid fillers. Tell your doctor if you plan other cosmetic treatments (i.e. laser treatments).
Tell your doctor if you are taking medications that decrease the body's immune response or affect bleeding, such as aspirin or warfarin, as these medications may increase the risk of bruising or bleeding at the gel injection site. The use of these products in gel injection sites with skin sores, pimples, rashes, hives, cysts or infections should be postponed until healing is complete. The most common side effects are swelling, redness, pain, bruising, headache, tenderness, lumping, itching at the injection site, and impaired hand function. Serious but rare side effects include late-onset infections, recurrence of herpetic eruptions, and superficial necrosis at the injection site. The risk of an involuntary injection into a blood vessel is small, but it can occur and lead to serious complications, which can be permanent, such as vision abnormalities, blindness, stroke, temporary scabs, or permanent scarring of the skin. As with all skin injection procedures, there is a risk of infection. Restylane is most commonly used to enhance the lips (volume and contour).
It is used to decrease wrinkles and aging lines on the face, such as nasolabial folds (lines from nose to mouth) and melomental folds (sad corners of the mouth). It can also be used to fill facial gaps and orbital canals related to aging (under and around the eyes), as well as for the volume of the cheeks and the contour of the chin, lips and nose. A treatment with a dermal filler such as Restylane may cause some temporary bruising, as well as swelling and numbness for a few days. In rare cases, lumps or granulomas have been reported. These side effects can be easily reversed with a treatment of hyaluronidase, which is an enzyme that accelerates the natural degradation of the injected hyaluronic acid filler. Several studies have been conducted to understand the long-term side effects of restylane and other hyaluronic acid fillers.
In certain cases, the filler causes a granulomatous reaction to a foreign body. Although side effects are rare, Restylane should not be used in areas where there are or have been skin diseases, inflammation or related conditions. Restylane has not been tested in pregnant or breast-feeding women. Most injectors inject the filler with a small needle under the skin. Anesthetic creams or injections reduce pain.
The FDA knows that unapproved versions of Juvederm, such as Juvederm Ultra 2, 3, and 4, have been sold and distributed in the United States. Group B compared injection of Restylane Contour with needle (n%3d60) and cannula (n%3d60) devices in the same patient* on each side of the face. FDA approval of Restylane Contour is supported by data from a pivotal, multicenter, randomized, comparator-controlled, phase 3 study conducted in 15 centers in the United States. When FDA approves a new dermal filler or approved dermal filler for a new indication for use, a Summary of Safety and Efficacy Data is published containing information on clinical and non-clinical data reviewed by the FDA and determined to support reasonable assurance of safety and efficacy. FDA approval is based on a review of data collected from controlled clinical studies that evaluated the safe and effective use of wrinkle fillers when injected into specific areas of facial tissue and hands. For nearly 10 years Galderma will work closely with its aesthetic injector partners while following all safe and appropriate social distancing guidelines to present their latest offer with Restylane Defyne for chin at respective practice centers across the country. A doctor (dermatologist or plastic surgeon) injects Restylane Defyne gel into the chin area to temporarily add volume and fullness. Restylane's product portfolio includes Restylane Lyft Restylane Kysse Restylane Volyme Restylane Defyne Restylane Refyne and Restylane Skinboosters. A doctor (dermatologist or plastic surgeon) injects Restylane Contour into the cheeks or middle of the face to temporarily add volume and fullness.
For nearly 10 years Galderma will work closely with its aesthetic injector partners while following all safe and appropriate social distancing guidelines to introduce their newest offering with Restylane Defyne for chin at respective practice locations across U. S.
